Coya Therapeutics
COYA
Coya Therapeutics (COYA) news
Recent news
Coya Therapeutics Q2 EPS USD -0.28
AInvest Wire · Aug 11, 2026Coya Therapeutics gets FDA fast track designation for Coya 302
Coya Therapeutics, Inc. (NASDAQ: COYA) has received FDA fast track designation for its investigational biologic therapy, COYA 302, for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). This designation is intended to…
AInvest Wire · May 12, 2026Coya Therapeutics to sell $26.5 million of stock in private placement
AInvest Wire · Dec 6, 2023Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.